Effect of STK11 mutations on efficacy of PD-1 inhibition in non-small cell lung cancer (NSCLC) and dependence on KRAS mutation status Meeting Abstract

  

Authors:	Ricciuti, B.; Arbour, K. C.; Lin, J. J.; Vokes, N.; Hoojghan, A. V.; Li, Y. Y.; Cherniack, A. D.; Recondo, G.; Lamberti, G.; Venkatraman, D.; Rizvi, H.; Egger, J. V.; Plodkowski, A. J.; Khosrowjerdi, S.; Digumarthy, S. R.; Nishino, M.; Sholl, L. M.; Gainor, J. F.; Hellmann, M. D.; Awad, M. M.
Abstract Title:	Effect of STK11 mutations on efficacy of PD-1 inhibition in non-small cell lung cancer (NSCLC) and dependence on KRAS mutation status
Meeting Title:	56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	38
Issue:	15 Suppl.
Meeting Dates:	2020 May 29-31
Meeting Location:	Virtual
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2020-05-20
Language:	English
ACCESSION:	WOS:000560368305105
PROVIDER:	wos
DOI:	10.1200/JCO.2020.38.15_suppl.e15113
Notes:	Meeting Abstract: e15113 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/179159